INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Similar documents
ASEAN GUIDELINES FOR VALIDATION OF ANALYTICAL PROCEDURES

serve the goal of analytical lmethod Its data reveals the quality, reliability and consistency of

Modern Analytical Techniques in Pharmaceuticals

Chapter 4: Verification of compendial methods

VALIDATION OF ANALYTICAL METHODS. Presented by Dr. A. Suneetha Dept. of Pharm. Analysis Hindu College of Pharmacy

Guidance for Industry

International Journal of Pharmacy and Pharmaceutical Sciences ISSN Vol 2, Suppl 3, 2010

VALIDATION OF ANALYTICAL METHODS FOR PHARMACEUTICAL ANALYSIS

Analytical Method Validation: An Updated Review

Validation of analytical methods. Adrian Covaci Toxicological Center, University of Antwerp

Guidance for Industry M4: The CTD General Questions and Answers

SWGDRUG GLOSSARY. Independent science-based organization that has the authority to grant

Quality by Design and Analytical Methods

Method Validation Essentials, Limit of Blank, Limit of Detection and Limit of Quantitation

REVIEW. Comparison of various international guidelines for analytical method validation

The Role of and the Place of Method Validation in Drug Analysis Using Electroanalytical Techniques

Work plan & Methodology: HPLC Method Development

Part IVB Quality Assurance/Validation of Analytical Methods

PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS.

Analytical Performance & Method. Validation

EFFECT OF THE UNCERTAINTY OF THE STABILITY DATA ON THE SHELF LIFE ESTIMATION OF PHARMACEUTICAL PRODUCTS

Ministry of Health MS Brazilian Health Surveillance Agency - ANVISA

Rosemary extract liquid

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS

Validation of an Analytical Method

M4 Implementation Working Group Questions & Answers (R3) Current version dated June 10, 2004

Method Development and Validation of Tramadol Hydrochloride by RP-HPLC Method

Analytical Methods Validation

Validation and Standardization of (Bio)Analytical Methods

4.A.1 Discussion. Assay method development and Validation of Ziprasidone Hydrochloride

A Laboratory Guide to Method Validation, (Eurachem).

THE USE OF IONISING RADIATION IN THE MANUFACTURE OF MEDICINAL PRODUCTS

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID

METHOD 8033 ACETONITRILE BY GAS CHROMATOGRAPHY WITH NITROGEN-PHOSPHORUS DETECTION

Limit of Detection and Its Establishment in Analytical Chemistry

OA03 UNCERTAINTY OF MEASUREMENT IN CHEMICAL TESTING IN ACCORDANCE WITH THE STANDARD SIST EN ISO/IEC Table of contents

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP)

Starting Materials For Active Substances

To control the consistency and quality

OF ANALYSIS FOR DETERMINATION OF PESTICIDES RESIDUES IN FOOD (CX/PR 15/47/10) European Union Competence European Union Vote

Method Validation. Role of Validation. Two levels. Flow of method validation. Method selection

International Journal of Pharmaceutical Research & Analysis

Protocol for the design, conducts and interpretation of collaborative studies (Resolution Oeno 6/2000)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

Introduction to Pharmaceutical Chemical Analysis

BIOANALYTICAL METHOD VALIDATION M10

Substance Characterisation for REACH. Dr Emma Miller Senior Chemist

ISO/TS TECHNICAL SPECIFICATION. Water quality Guidance on analytical quality control for chemical and physicochemical water analysis

Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)

Mean Kinetic Temperature

GC METHOD FOR QUANTITATIVE DETERMINATION OF RESIDUAL 2-(2-CHLOROETHOXY)ETHANOL (CEE) AND N-METHYL-2-PYRROLIDINONE (NMP) IN QUETIAPINE

3.1.1 The method can detect, identify, and potentially measure the amount of (quantify) an analyte(s):

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016

DEVELOPMENT AND VALIDATION OF GC-FID METHOD FOR THE DETERMINATION OF ETHANOL RESIDUE IN MARJORAM OINTMENT

The role of the authorities, SVHC substances, data issues

Draft Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development. (24 January, 2014, MHLW, Japan)

Unified Approach For Performing An Analytical Methods Comparability Study IVT s LAB WEEK Presenter: Peter M. Saama, Ph.D. Bayer HealthCare LLC

Guide to Registration Requirements for Active Substance Manufacturers, Importers and Distributors in Ireland

Application of RIP 3.10 on Guidance for identification and naming of substances

Regulatory and Alternative Analytical Procedures are defined as follows 2 :

TESTING OF RESIDUAL FORMALDEHYDE

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

ICH guideline M10 on bioanalytical method validation

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

State-of-the-science in Metrology & Metrics for Nanomaterials Regulation

Substance identification. Chemical Watch Expo

Hach Method Spectrophotometric Measurement of Free Chlorine (Cl 2 ) in Finished Drinking Water

PHARMACEUTICAL BULLETINS

Substance identification and how to report it in IUCLID 6

VICH Topic GL25 BIOLOGICALS: TESTING OF RESIDUAL FORMALDEHYDE

TEAC Green Procurement Guideline

Validation of ACQUITY UPLC Methods

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Draft agreed by the QWP June Draft endorsed by the CMD(v) June Draft adopted by the CVMP for release for consultation July 2016

Low-level Determination of 4-Hydrazino Benzoic Acid in Drug Substance by High Performance Liquid Chromatography/Mass Spectrometry

CHAPTER 1 Role of Bioanalytical Methods in Drug Discovery and Development

Reflection paper on poorly extractable and/or nonradiolabelled

STUDY OF THE APPLICABILTY OF CONTENT UNIFORMITY AND DISSOLUTION VARIATION TEST ON ROPINIROLE HYDROCHLORIDE TABLETS

Validated spectrophotometric determination of Fenofibrate in formulation

Derogation Criteria for the Requirements for Generators Network Code

Development and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in Multicomponents Syrups and Tablets

Cleaning Memo for January 2017 A Critique of the APIC Guideline

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

The Theory of HPLC. Quantitative and Qualitative HPLC

CTD General Questions and Answers

ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Questions and Answers. Step 5

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

J Pharm Sci Bioscientific Res (4): ISSN NO

การใช REFERENCE STANDARDS ในการควบค มค ณภาพยา

How to develop an ATP.... and verify it has been met. Melissa Hanna-Brown Analytical R & D; Pfizer Global R+D, Sandwich UK.

Key concepts and dossier preparation, Part I

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

IDENTIFICATION AND QUANTITATION OF HARD-TO-RESOLVE INDIVIDUAL COMPONENTS IN MIXTURES WITHOUT CHROMATOGRAPHY, CHEMOMETRICS, AND REFERENCE STANDARDS

Document No: TR 12 Issue No: 1

Annex 3. General guidelines for the establishment, maintenance and distribution of chemical reference substances. Introduction.

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

Glossary of Common Laboratory Terms

Traceability, validation and measurement uncertainty 3 pillars for quality of measurement results. David MILDE

Transcription:

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE TEXT ON VALIDATION OF ANALYTICAL PROCEDURES Recommended for Adoption at Step 4 of the ICH Process on 27 October 1994 by the ICH Steering Committee This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. 1

TEXT ON VALIDATION OF ANALYTICAL PROCEDURES ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 27 October 1994, this guideline is recommended for adoption to the three regulatory parties to ICH 1. Introduction This document presents a discussion of the characteristics for consideration during the validation of the analytical procedures included as part of registration applications submitted within the EC, Japan and USA. This document does not necessarily seek to cover the testing that may be required for registration in, or export to, other areas of the world. Furthermore, this text presentation serves as a collection of terms, and their definitions, and is not intended to provide direction on how to accomplish validation. These terms and definitions are meant to bridge the differences that often exist between various compendia and regulators of the EC, Japan and USA. The objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose. A tabular summation of the characteristics applicable to identification, control of impurities and assay procedures is included. Other analytical procedures may be considered in future additions to this document. 2. Types of Analytical Procedures to be Validated The discussion of the validation of analytical procedures is directed to the four most common types of analytical procedures: Identification tests. Quantitative tests for impurities' content. Limit tests for the control of impurities. Quantitative tests of the active moiety in samples of drug substance or drug product or other selected component(s) in the drug product. Although there are many other analytical procedures, such as dissolution testing for drug products or particle size determination for drug substance, these have not been addressed in the initial text on validation of analytical procedures. Validation of these additional analytical procedures is equally important to those listed herein and may be addressed in subsequent documents. A brief description of the types of tests considered in this document is provided below. Identification tests are intended to ensure the identity of an analyte in a sample. This is normally achieved by comparison of a property of the sample (e.g., spectrum, chromatographic behavior, chemical reactivity, etc) to that of a reference standard. 2

Testing for impurities can be either a quantitative test or a limit test for the impurity in a sample. Either test is intended to accurately reflect the purity characteristics of the sample. Different validation characteristics are required for a quantitative test than for a limit test. Assay procedures are intended to measure the analyte present in a given sample. In the context of this document, the assay represents a quantitative measurement of the major component(s) in the drug substance. For the drug product, similar validation characteristics also apply when assaying for the active or other selected component(s). The same validation characteristics may also apply to assays associated with other analytical procedures (e.g., dissolution). The objective of the analytical procedure should be clearly understood since this will govern the validation characteristics which need to be evaluated. Typical validation characteristics which should be considered are listed below: Accuracy Precision Repeatability Intermediate Precision Specificity Detection Limit Quantitation Limit Linearity Range Each of these validation characteristics is defined in the attached Glossary. The table lists those validation characteristics regarded as the most important for the validation of different types of analytical procedures. This list should be considered typical for the analytical procedures cited but occasional exceptions should be dealt with on a case-by-case basis. It should be noted that robustness is not listed in the table but should be considered at an appropriate stage in the development of the analytical procedure. Furthermore revalidation may be necessary in the following circumstances: changes in the synthesis of the drug substance; changes in the composition of the finished product; changes in the analytical procedure; The degree of revalidation required depends on the nature of the changes. Certain other changes may require validation as well. 3

Type of analytical procedure Identification TABLE Quantitative test Impurity content Type of analytical procedure Limit test for impurities Assay - Dissolution - Content/ potency Specificity (2) x x x x Linearity x - x Quantitation limit x x - Detection limit - (3) - x Range x - x Accuracy - - Precision - -Repeatability - intermediate precision x X (1) - x X (1) - signifies that this characteristic is not normally evaluated + signifies that this characteristic is normally evaluated (1) in cases where reproducibility (see glossary) has been performed, intermediate precision is not needed (2) lack of specificity of one analytical procedure could be compensated by other supporting analytical procedure(s) (3) may be needed in some cases 4

GLOSSARY 1. ANALYTICAL PROCEDURE The analytical procedure refers to the way of performing the analysis. It should describe in detail the steps necessary to perform each analytical test. This may include but is not limited to: the sample, the reference standard and the reagents preparations, use of the apparatus, generation of the calibration curve, use of the formulae for the calculation, etc. 2. SPECIFICITY Specificity is the ability to assess unequivocally the analyte in the presence of components which may be expected to be present. Typically these might include impurities, degradants, matrix, etc. Lack of specificity of an individual analytical procedure may be compensated by other supporting analytical procedure(s). This definition has the following implications: Identification: to ensure the identity of an analyte. Purity Tests: to ensure that all the analytical procedures performed allow an accurate statement of the content of impurities of an analyte, i.e. related substances test, heavy metals, residual solvents content, etc. Assay (content or potency): to provide an exact result which allows an accurate statement on the content or potency of the analyte in a sample. 3. ACCURACY The accuracy of an analytical procedure expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and the value found. This is sometimes termed trueness. 4. PRECISION The precision of an analytical procedure expresses the closeness of agreement (degree of scatter) between a series of measurements obtained from multiple sampling of the same homogeneous sample under the prescribed conditions. Precision may be considered at three levels: repeatability, intermediate precision and reproducibility. Precision should be investigated using homogeneous, authentic samples. However, if it is not possible to obtain a homogeneous sample it may be investigated using artificially prepared samples or a sample solution. The precision of an analytical procedure is usually expressed as the variance, standard deviation or coefficient of variation of a series of measurements. 5

4.1. Repeatability Repeatability expresses the precision under the same operating conditions over a short interval of time. Repeatability is also termed intra-assay precision. 4.2. Intermediate precision Intermediate precision expresses within-laboratories variations: different days, different analysts, different equipment, etc. 4.3. Reproducibility Reproducibility expresses the precision between laboratories (collaborative studies, usually applied to standardization of methodology). 5. DETECTION LIMIT The detection limit of an individual analytical procedure is the lowest amount of analyte in a sample which can be detected but not necessarily quantitated as an exact value. 6. QUANTITATION LIMIT The quantitation limit of an individual analytical procedure is the lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy. The quantitation limit is a parameter of quantitative assays for low levels of compounds in sample matrices, and is used particularly for the determination of impurities and/or degradation products. 7. LINEARITY The linearity of an analytical procedure is its ability (within a given range) to obtain test results which are directly proportional to the concentration (amount) of analyte in the sample. 8. RANGE The range of an analytical procedure is the interval between the upper and lower concentration (amounts) of analyte in the sample (including these concentrations) for which it has been demonstrated that the analytical procedure has a suitable level of precision, accuracy and linearity. 9. ROBUSTNESS The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. 6